» Articles » PMID: 36341412

Common Molecular Mechanism and Immune Infiltration Patterns of Thoracic and Abdominal Aortic Aneurysms

Overview
Journal Front Immunol
Date 2022 Nov 7
PMID 36341412
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Aortic disease (aortic aneurysm (AA), dissection (AD)) is a serious threat to patient lives. Little is currently known about the molecular mechanisms and immune infiltration patterns underlying the development and progression of thoracic and abdominal aortic aneurysms (TAA and AAA), warranting further research.

Methods: We downloaded AA (includes TAA and AAA) datasets from the GEO database. The potential biomarkers in TAA and AAA were identified using differential expression analysis and two machine-learning algorithms. The discrimination power of the potential biomarkers and their diagnostic accuracy was assessed in validation datasets using ROC curve analysis. Then, GSEA, KEGG, GO and DO analyses were conducted. Furthermore, two immuno-infiltration analysis algorithms were utilized to analyze the common immune infiltration patterns in TAA and AAA. Finally, a retrospective clinical study was performed on 78 patients with AD, and the serum from 6 patients was used for whole exome sequencing (WES).

Results: The intersection of TAA and AAA datasets yielded 82 differentially expressed genes (DEGs). Subsequently, the biomarkers ( and ) were acquired by screening using two machine-learning algorithms and ROC curve analysis. The functional analysis of DEGs showed significant enrichment in inflammation and regulation of angiogenic pathways. Immune cell infiltration analysis revealed that adaptive and innate immune responses were closely linked to AA progression. However, neither nor was associated with B cell-mediated humoral immunity. expression was correlated with macrophages and with eosinophils. Finally, our retrospective clinical study revealed a hyperinflammatory environment in aortic disease. The WES study identified disease biomarkers and gene variants, some of which may be druggable.

Conclusion: The genes and can be used as common biomarkers in TAA and AAA. Large numbers of innate and adaptive immune cells are infiltrated in AA and are closely linked to the development and progression of AA. Moreover, and are highly correlated with the infiltration of immune cells and may be potential targets of immunotherapeutic drugs. Gene mutation research is a promising direction for the treatment of aortic disease.

Citing Articles

Identification and mechanism analysis of biomarkers related to butyrate metabolism in COVID-19 patients.

Zhou W, Li H, Zhang J, Liu C, Liu D, Chen X Ann Med. 2025; 57(1):2477301.

PMID: 40074706 PMC: 11905318. DOI: 10.1080/07853890.2025.2477301.


Atractylenolide-I prevents abdominal aortic aneurysm formation through inhibiting inflammation.

Chen S, Liu X, Zhou X, Lin W, Liu M, Ma H Front Immunol. 2025; 16:1486072.

PMID: 39958337 PMC: 11825332. DOI: 10.3389/fimmu.2025.1486072.


A bibliometric and visualization analysis of global trends and frontiers on macrophages in abdominal aortic aneurysms research.

Zhang L, Li D, Bao S Medicine (Baltimore). 2024; 103(43):e40274.

PMID: 39470505 PMC: 11521088. DOI: 10.1097/MD.0000000000040274.


HMGCR as a promising molecular target for therapeutic intervention in aortic aneurisms: a mendelian randomization study.

Zheng P, Zheng Z, Liu Z, He J, Rong J, Pan H Nutr Metab (Lond). 2024; 21(1):81.

PMID: 39402528 PMC: 11472594. DOI: 10.1186/s12986-024-00849-1.


Deciphering the causal association and underlying transcriptional mechanisms between telomere length and abdominal aortic aneurysm.

Zhang J, Xia X, He S Front Immunol. 2024; 15:1438838.

PMID: 39234237 PMC: 11371612. DOI: 10.3389/fimmu.2024.1438838.


References
1.
Pisano C, Balistreri C, Ricasoli A, Ruvolo G . Cardiovascular Disease in Ageing: An Overview on Thoracic Aortic Aneurysm as an Emerging Inflammatory Disease. Mediators Inflamm. 2017; 2017:1274034. PMC: 5674506. DOI: 10.1155/2017/1274034. View

2.
Ito K, Murphy D . Application of ggplot2 to Pharmacometric Graphics. CPT Pharmacometrics Syst Pharmacol. 2013; 2:e79. PMC: 3817376. DOI: 10.1038/psp.2013.56. View

3.
Patel A, Jagadesham V, Porter K, Scott D, Carding S . Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease. Eur J Vasc Endovasc Surg. 2008; 36(1):20-7. DOI: 10.1016/j.ejvs.2008.01.014. View

4.
Shen Y, LeMaire S, Webb N, Cassis L, Daugherty A, Lu H . Aortic Aneurysms and Dissections Series. Arterioscler Thromb Vasc Biol. 2020; 40(3):e37-e46. PMC: 7233726. DOI: 10.1161/ATVBAHA.120.313991. View

5.
Martin-Ventura J, Martinez-Lopez D, Roldan-Montero R, Gomez-Guerrero C, Blanco-Colio L . Role of complement system in pathological remodeling of the vascular wall. Mol Immunol. 2019; 114:207-215. DOI: 10.1016/j.molimm.2019.06.016. View